Advocating for U.S. Agricultural Biotechnology Leadership
Protecting U.S. Leadership in Agricultural Biotechnology
Georgia Life Sciences has joined with leading scientific societies and state bioscience associations in signing a stakeholder letter to USDA regarding its proposed reorganization plan. Together, we urged the Department to keep Biotechnology Regulatory Services (BRS) staff based in the National Capital Region (NCR).
BRS provides critical oversight for the importation, interstate movement, and environmental release of crops, insects, and microbes developed through modern genetic techniques. Its expertise is central to ensuring that agricultural innovation moves forward safely, efficiently, and competitively.
Maintaining BRS in the NCR is not just about convenience—it is about preserving effective coordination across federal agencies. BRS works closely with the FDA and EPA as part of the Coordinated Framework for the Regulation of Biotechnology. The proximity of these agencies allows for faster decisions, clearer communication, and stronger support for stakeholders.
Relocating BRS staff outside of Washington would risk delays in approvals, loss of critical expertise, and reduced stakeholder engagement. It would weaken the nation’s ability to keep pace with global competitors at a time when agricultural biotechnology is rapidly advancing.
As the letter notes, the United States cannot afford to diminish BRS’s capacity. Farmers, innovators, and patients alike rely on this regulatory expertise to bring forward the next generation of agricultural solutions. Georgia Life Sciences is proud to stand alongside our partners in calling on USDA to maintain BRS’s presence in the National Capital Region and protect America’s leadership in agricultural biotechnology.
